| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/10/1999 | CA2311598A1 Dna encoding phage resistance protein |
| 06/10/1999 | CA2311574A1 Cells expressing anti-fc receptor binding components |
| 06/10/1999 | CA2311332A1 Cruciform binding protein |
| 06/10/1999 | CA2310541A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening |
| 06/10/1999 | CA2309810A1 Erythropoietin with high specific activity |
| 06/10/1999 | CA2309806A1 Hydrophobically-modified protein compositions and methods |
| 06/10/1999 | CA2309534A1 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment |
| 06/10/1999 | CA2309228A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 06/09/1999 | EP0921194A2 TRAILLK-2: a member of the TNF ligand family |
| 06/09/1999 | EP0921193A1 Carrier: DNA complexes containing DNA encoding anti-angiogenic peptides and their use in gene therapy |
| 06/09/1999 | EP0921192A1 Molecules interacting with apoptin |
| 06/09/1999 | EP0921132A1 Novel human receptor type tyrosine kinase-like protein |
| 06/09/1999 | EP0921131A1 Chemically modified polypeptides |
| 06/09/1999 | EP0920630A2 Prion protein binding proteins and uses thereof |
| 06/09/1999 | EP0920629A1 Improved western blot test for the identification of antibodies specific against the hcmv virus |
| 06/09/1999 | EP0920534A1 MUTATIONS IN THE DIABETES SUSCEPTIBILITY GENES HEPATOCYTE NUCLEAR FACTOR (HNF) 1 ALPHA ($g(a)), HNF-1$g(b) AND HNF-4$g(a) |
| 06/09/1999 | EP0920528A1 Synthetic protein folding catalysis |
| 06/09/1999 | EP0920524A1 A short-shafted adenoviral fiber and its use |
| 06/09/1999 | EP0920523A1 Hsv strain lacking functional icp27 and icp34.5 genes |
| 06/09/1999 | EP0920522A1 A vector for polynucleotide vaccines |
| 06/09/1999 | EP0920518A1 Stimulus-inducible i (kappa)b kinase ikk] signalsome |
| 06/09/1999 | EP0920514A1 Targeting adenovirus with use of constrained peptide motifs |
| 06/09/1999 | EP0920513A2 DEFINING EPITOPES OF THE OUTER MEMBRANE PROTEIN CopB OF MORAXELLA CATARRHALIS |
| 06/09/1999 | EP0920512A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 06/09/1999 | EP0920511A1 Expression vectors, cells, and methods for preparing thrombopoietin polypeptides |
| 06/09/1999 | EP0920510A1 GnRH-LEUKOTOXIN CHIMERAS |
| 06/09/1999 | EP0920509A1 Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
| 06/09/1999 | EP0920508A1 HUMAN POLYHOMEOTIC 1 ($i(hph1)) ACTS AS AN ONCOGENE |
| 06/09/1999 | EP0920507A2 Secreted proteins and polynucleotides encoding them |
| 06/09/1999 | EP0920506A1 Human dbi/acbp-like protein |
| 06/09/1999 | EP0920505A1 Mammalian cell surface antigens; related reagents |
| 06/09/1999 | EP0920504A2 Voltage-gated calcium channel antagonist and methods |
| 06/09/1999 | EP0920503A2 A novel human leptin receptor gene-related protein |
| 06/09/1999 | EP0920502A1 Methods and means for modifying complement activation |
| 06/09/1999 | EP0920501A1 Neuritin, a neurogene |
| 06/09/1999 | EP0920500A1 Human proteolipid |
| 06/09/1999 | EP0920499A2 Polynucleotides encoding secreted proteins |
| 06/09/1999 | EP0920498A1 HAMSTER EF-1$g(a) TRANSCRIPTIONAL REGULATORY DNA |
| 06/09/1999 | EP0920495A1 Transgenic animal model for alzheimer disease |
| 06/09/1999 | EP0920453A1 Fluorescent peptides |
| 06/09/1999 | EP0920452A1 Novel osteopontin derived chemotactic peptides and methods of use |
| 06/09/1999 | EP0920451A1 Novel peptides suitable for use in antigen specific immunosuppressive therapy |
| 06/09/1999 | EP0920450A2 Plag gene family and tumorigenesis |
| 06/09/1999 | EP0920449A2 Peptides |
| 06/09/1999 | EP0920448A1 Truncated glial cell line-derived neurotrophic factor |
| 06/09/1999 | EP0920446A1 Conformationally constrained backbone cyclized somatostatin analogs |
| 06/09/1999 | EP0920443A1 Activated peptides and conjugates |
| 06/09/1999 | EP0920328A1 Allogeneic histocompatibility complexes as mediators of cell destruction |
| 06/09/1999 | EP0920326A1 Antithrombotic materials and methods |
| 06/09/1999 | EP0920305A1 Identification of genes altered in multiple myeloma |
| 06/09/1999 | EP0920254A1 Programmed cell death and ich-3 |
| 06/09/1999 | EP0839045A4 Interleukin-1 receptor-associated protein kinase and assays |
| 06/09/1999 | EP0661986B1 Brain-enhanced delivery of neuroactive peptides by sequential metabolism |
| 06/09/1999 | EP0631597B1 Super porous polysaccharide gels |
| 06/09/1999 | EP0620740B1 Injectable lecithin gel |
| 06/09/1999 | CN1219240A Purification of tissue plasminogen activator |
| 06/09/1999 | CN1219175A Zona pellucida proteins for contraception |
| 06/09/1999 | CN1219133A Administration of polypeptide growth factors following central nervous system ischemia or trauma |
| 06/09/1999 | CN1218833A Polypeptide with cell withering promoting activity |
| 06/09/1999 | CN1218813A Method for preparing medicine using silkworm produced recombined human thrombocytopoietic factor |
| 06/09/1999 | CN1218812A Method for preparing medicine using silkworm expressed recombined human erythropoietin |
| 06/09/1999 | CA2218199A1 Short gcg expansions in the pab ii gene for oculopharyngeal muscular dystrophy and diagnostic thereof |
| 06/08/1999 | US5910629 Chimeric genes comprising a fungus-responsive element |
| 06/08/1999 | US5910627 Ph genes and their uses |
| 06/08/1999 | US5910582 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 06/08/1999 | US5910580 Streptococcus pneumoniae gene sequence HI1648 |
| 06/08/1999 | US5910576 Method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein |
| 06/08/1999 | US5910575 Monoclonal antibody which binds to (125)i-labeled derivatives of cortisol-3-carboxymethyloxime-histamine and preferentially binds to unlabeled syn isomer over unlabeled anti isomer; for competitive radioimmunoassay |
| 06/08/1999 | US5910574 Human trk receptors and neurotrophic factor inhibitors |
| 06/08/1999 | US5910573 Monomeric and dimeric antibody-fragment fusion proteins |
| 06/08/1999 | US5910572 Response regulator peptides; for screening bactericides |
| 06/08/1999 | US5910571 DNA encoding phage abortive infection protein from Lactococcus lactis and method of use thereof |
| 06/08/1999 | US5910568 Molecule involved in binding of sperm to egg surfaces and procedures for use of this molecule to enhance or decrease potential fertility |
| 06/08/1999 | US5910488 Plasmids suitable for gene therapy |
| 06/08/1999 | US5910483 Drug for treatment of growth related disorders, gastrointstinal tract diseases, anorexia nervosa and mammary cancer |
| 06/08/1999 | US5910481 Hybrid proteins with modified activity |
| 06/08/1999 | US5910480 (early placenta insulin-like peptide) molecule of the insulin family; induces dna synthesis, tyrosine phosphorylation |
| 06/08/1999 | US5910478 Peptidomimetics inhibiting the oncogenic action of p21 ras |
| 06/08/1999 | US5910451 Trophinin and trophinin-assisting proteins |
| 06/08/1999 | US5910442 Nucleic acid coding for substrate of protein kinase c inserting it into a expression vector; transforming a host; anticarcinogenic agents |
| 06/08/1999 | US5910441 DNA encoding fibronectin and fibrinogen binding protein from group A streptococci |
| 06/08/1999 | US5910437 Ligated d-protein of formula r-l-r' where r and r' are peptides and l is linking group of thiol ester or selenol ester; for production of chirally pure chemicals and drugs; production of racemic crystals; prolonged half-life in body |
| 06/08/1999 | US5910435 Exposing protein with non-native disulfide bonds to non-protein compound with pka less than 8 and eo greater than -0.25 volts; for proper conformation of heterologous eukaryotic proteins from prokaryotic hosts |
| 06/08/1999 | US5910431 Polynucleotides encoding chemokine α-2 |
| 06/08/1999 | US5910430 Isolated nucleic acid encoding G-protein coupled receptor (HTADX50) |
| 06/08/1999 | US5910428 Dna which codes for corticotropin-releasing factor binding protein; treating of eating disorders, alcholism; hypertensive agents |
| 06/08/1999 | US5910427 Protein derivatives formed by replacement, substitution, or chemical modification of amino acids 57 and/or 60 having increased activity; for immunosuppressives/allergy treatments |
| 06/08/1999 | US5910418 Immunoassay to identify prematurely terminated gene products; diagnosis of familial adenomatous polyposis |
| 06/08/1999 | US5910417 Controlling allergic inflammation; by administering to humans a compound which interacts with kinase signal tranduction pathway, suppressing cytokine production |
| 06/08/1999 | US5910416 Adrenomedullin |
| 06/08/1999 | US5910409 Nucleic acid for use as primer for diagnosis of canidia albicans infection |
| 06/08/1999 | US5910405 HCV diagnostic agents |
| 06/08/1999 | US5910404 Amino acid sequence of peptide mimetic; for screening blood and blood products; use as immunogens |
| 06/08/1999 | US5910310 Genetic engineered antigenic material comprising isolated whole cell culture particles as a vaccine preventing viral diseases |
| 06/08/1999 | US5910309 UV-induced factor for immunosuppression |
| 06/08/1999 | US5910252 Medical device for hemodialysis, ultrafiltration, hemofiltration, and other blood treatments; for automatic performance and monitoring; pumps, replacement fluid supplies, tubes, reservoirs, controllers, computers, instrument panels |
| 06/08/1999 | CA2242308A1 Novel compounds |
| 06/08/1999 | CA1340586C Process for recovering microbially produced interferon-beta |
| 06/08/1999 | CA1340580C Recombinant alveolar surfactant protein |
| 06/05/1999 | CA2218197A1 Therapeutic methods for prostate cancer |